We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.29B
AUM Growth
+$160M
Cap. Flow
+$8.37M
Cap. Flow %
0.16%
Top 10 Hldgs %
23.19%
Holding
318
New
66
Increased
91
Reduced
86
Closed
36

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$80.3M
2
PFE icon
Pfizer
PFE
+$58.1M
3
HCA icon
HCA Healthcare
HCA
+$35M
4
JNJ icon
Johnson & Johnson
JNJ
+$34.9M
5
EVHC
Envision Healthcare Holdings Inc
EVHC
+$28.7M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$40.7M
2
RTX icon
RTX Corp
RTX
+$40.3M
3
ABT icon
Abbott
ABT
+$31.8M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$29.2M
5
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$28.6M

Sector Composition

Rank Sector Weight
1 Technology 26.44%
2 Healthcare 24.73%
3 Financials 20.02%
4 Communication Services 11.49%
5 Consumer Discretionary 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUNE
251
DELISTED
SUNEDISON, INC COM
SUNE
$411K 0.01%
+17,000
New +$365K
PRQR icon
252
ProQR Therapeutics
PRQR
$250M
$360K 0.01%
16,447
-2,307
-12% -$47.6K
AXP icon
253
American Express
AXP
$225B
$350K 0.01%
+4,483
New +$372K
PB icon
254
Prosperity Bancshares
PB
$8.9B
$326K 0.01%
6,205
-568
-8% -$28.9K
TBRA
255
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$275K 0.01%
+25,000
New +$268K
QIWI
256
DELISTED
QIWI PLC
QIWI
$268K 0.01%
11,172
+717
+7% +$15.8K
KYNB
257
Kyntra Bio
KYNB
$28.1M
$260K ﹤0.01%
+332
New +$257K
VTAE
258
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$260K ﹤0.01%
+22,238
New +$300K
ACOR
259
DELISTED
Acorda Therapeutics
ACOR
$254K ﹤0.01%
+64
New +$293K
CARM
260
DELISTED
Carisma Therapeutics
CARM
$250K ﹤0.01%
+1,402
New +$306K
ALKS icon
261
Alkermes
ALKS
$8.13B
$246K ﹤0.01%
4,038
-2,083
-34% -$142K
AAPL icon
262
CALL
Apple
AAPL
$5.02T
– –
-247,680
Closed -$6.83M
AFMD
263
DELISTED
Affimed
AFMD
– –
-3,696
Closed -$229K
AGEN
264
Agenus
AGEN
$283M
– –
-3,227
Closed -$251K
CSIQ icon
265
Canadian Solar
CSIQ
$938M
– –
-118,888
Closed -$2.87M
FAF icon
266
First American
FAF
$8.08B
– –
-508,677
Closed -$17.2M
CBIO
267
Crescent Biopharma
CBIO
$546M
– –
-160
Closed -$115K
HUM icon
268
Humana
HUM
$44.2B
– –
-176,401
Closed -$25.3M
LSCC icon
269
Lattice Semiconductor
LSCC
$16.4B
– –
-1,291,139
Closed -$8.9M
NOW icon
270
ServiceNow
NOW
$121B
– –
-512,590
Closed -$6.95M
PARA
271
DELISTED
Paramount Global Class B
PARA
– –
-247,031
Closed -$13.7M
PM icon
272
Philip Morris
PM
$310B
– –
-253,766
Closed -$20.7M
PRO
273
DELISTED
PROS Holdings
PRO
– –
-200,934
Closed -$5.52M
SNPS icon
274
Synopsys
SNPS
$72.9B
– –
-99,088
Closed -$4.31M
SPSC icon
275
SPS Commerce
SPSC
$2.57B
– –
-79,758
Closed -$2.25M
8 9 10
11
12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Polar Capital held 318 positions worth $5.29B, up 3.1% from $5.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital's Q1 2015 filing shows 66 new, 91 increased, 86 reduced and 36 closed positions. Its largest new stake was Envision Healthcare Holdings Inc: 263,860 shares worth $30.3M. The largest sale was Microsoft, an estimated $40.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2015 buy was Envision Healthcare Holdings Inc: 263,860 shares worth $30.3M.
  • Polar Capital added most to Thermo Fisher Scientific in Q1 2015, an estimated $80.3M increase.
  • Polar Capital's biggest Q1 2015 reduction was Microsoft, cutting an estimated $40.7M.
  • Polar Capital fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $29.2M.
  • Polar Capital's ten largest holdings make up 23% of its $5.29B portfolio in Q1 2015.
  • Polar Capital opened 66 new positions and closed 36 in Q1 2015.
  • Polar Capital's portfolio value rose 3.1% quarter-over-quarter to $5.29B.

Based on Polar Capital's 13F filing for Q1 2015, filed 15 May 2015.